BIOMAT Database Logo BIOMAT Database Logo

Antimalarial activity of the 8-aminoquinolines. 1991

E A Nodiff, and S Chatterjee, and H A Musallam
Franklin Research Center, Arvin Calspan Corporation, Norristown, PA 19403.

UI MeSH Term Description Entries
D008288 Malaria A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. Marsh Fever,Plasmodium Infections,Remittent Fever,Infections, Plasmodium,Paludism,Fever, Marsh,Fever, Remittent,Infection, Plasmodium,Plasmodium Infection
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010961 Plasmodium A genus of protozoa that comprise the malaria parasites of mammals. Four species infect humans (although occasional infections with primate malarias may occur). These are PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM OVALE, and PLASMODIUM VIVAX. Species causing infection in vertebrates other than man include: PLASMODIUM BERGHEI; PLASMODIUM CHABAUDI; P. vinckei, and PLASMODIUM YOELII in rodents; P. brasilianum, PLASMODIUM CYNOMOLGI; and PLASMODIUM KNOWLESI in monkeys; and PLASMODIUM GALLINACEUM in chickens. Plasmodiums
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000634 Aminoquinolines Quinolines substituted in any position by one or more amino groups.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000962 Antimalarials Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) Anti-Malarial,Antimalarial,Antimalarial Agent,Antimalarial Drug,Anti-Malarials,Antimalarial Agents,Antimalarial Drugs,Agent, Antimalarial,Agents, Antimalarial,Anti Malarial,Anti Malarials,Drug, Antimalarial,Drugs, Antimalarial
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

E A Nodiff, and S Chatterjee, and H A Musallam
Three 4-aminoquinolines of antimalarial interest.
February 2006, Acta crystallographica. Section C, Crystal structure communications,
E A Nodiff, and S Chatterjee, and H A Musallam
Synthesis, cytotoxicity and antimalarial activity of ferrocenyl amides of 4-aminoquinolines.
January 2010, Arzneimittel-Forschung,
E A Nodiff, and S Chatterjee, and H A Musallam
Antimalarial activity of novel 4-aminoquinolines active against drug resistant strains.
February 2017, Bioorganic chemistry,
E A Nodiff, and S Chatterjee, and H A Musallam
[Antimalarial 6-aminoquinolines. IV (author's transl)].
October 1974, Archiv der Pharmazie,
E A Nodiff, and S Chatterjee, and H A Musallam
Potentiation of the curative action of antimalarial agents, with special reference to 8-aminoquinolines and naphthoquinones.
November 1947, Journal of bacteriology,
E A Nodiff, and S Chatterjee, and H A Musallam
Pharmacology of 8-aminoquinolines.
January 1981, Bulletin of the World Health Organization,
E A Nodiff, and S Chatterjee, and H A Musallam
The synthesis of some 8-aminoquinolines.
August 1946, Journal of the American Chemical Society,
E A Nodiff, and S Chatterjee, and H A Musallam
Activity of certain 6-methoxy-8-aminoquinolines against Trypanosoma cruzi.
May 1952, Antibiotics & chemotherapy (Northfield, Ill.),
E A Nodiff, and S Chatterjee, and H A Musallam
Antimalarial 4-aminoquinolines: mode of action and pharmacokinetics.
January 1994, Fundamental & clinical pharmacology,
E A Nodiff, and S Chatterjee, and H A Musallam
The inhibition in vitro of bacterial DNA polymerases and RNA polymerase by antimalarial 8-aminoquinolines and by chloroquine.
November 1972, Biochimica et biophysica acta,
Copied contents to your clipboard!